Series B Biotechnology Companies

Prolific Machines unlocks production of next-generation therapeutics with a light-controlled gene expression system and closed-loop control.

GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

CinRx Pharma develops therapies for unmet needs, leveraging partnerships and expertise to advance new molecular entities.

INCOG BioPharma services include injectable drug product formulation, analytical method, process scale up, and formulation.

We are advancing novel antigen modulation technology that controls T cells to guide the immune system.

Enifer is a mycoprotein company that produces a fungal fermentation product to upcycle agrifood industry byproducts.

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

Elegen is a biotechnology company that develops microfluidic technology.

Qlaris Bio focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.

Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.

Infinited Fiber Company is on a mission to make circular fashion and textiles an everyday reality

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Othram aims to revolutionize how forensic cases are solved, justice is served, and families are mended.

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.

Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.

Our purpose is to make every pregnancy around the world safer.